Salvatore Vanchieri Jr.

Associate
New York
  • 1271 Avenue of the Americas
  • New York, NY 10020
  • USA
Profile Experience

Salvatore Vanchieri, a member of the Capital Markets Practice, represents financial institutions, private equity firms, and issuer clients in a variety of complex corporate finance and capital markets transactions.

Mr. Vanchieri advises clients on a broad range of domestic and cross-border financing transactions, including:

  • Acquisition financings and exchange offers
  • High-yield and investment grade debt offerings
  • Initial public offerings
  • Preferred equity financings
  • SEC related matters, corporate governance, and other general corporate matters

He brings experience advising on transactions across a broad array of industries, including technology, consumer retail, and healthcare.

Mr. Vanchieri’s experience includes advising:

  • Morgan Stanley in the US$850 million initial public offering for American Well Corporation
  • BofA Securities in connection with:
    • US$278 million initial public offering for Outset Medical
    • US$300 million senior notes offering for Cumberland Farms
    • US$304 million initial public offering for YETI Holdings
  • The underwriters in connection with the US$350 million offering of senior secured notes by Abercrombie & Fitch Management
  • Zentalis Pharmaceuticals in its US$190 million initial public offering
  • Citigroup in the US$800 million offering of senior notes by Presidio Holdings
  • Jefferies in the US$335 million senior notes offering by Truck Hero
  • Barclays in connection with the US$1.3 billion senior notes offering for McDermott Technology (Americas)
  • Credit Suisse in connection with the US$1.25 billion common stock offering for SS&C Technologies Holdings
  • JP Morgan in the US$378 million initial public offering by Acushnet Holdings
  • The lenders in the US$4 billion Tengizchevroil Future Growth and Wellhead Pressure Management Project, an expansion of the Tengizchevroil crude oil processing facilities in Kazakhstan
  • Teladoc in its US$180 million initial public offering
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.